){kind=logo}
){kind=logo}
Biopharmaceutical Characterization in the Age of Artificial Intelligence
• Examine how AI models support the design of bifunctional molecules for targeted protein degradation.
• Explore strategies for predicting ternary complex formation, linker optimization and degrader selectivity.
• Assess how computational approaches are accelerating the discovery of molecular glues and next-generation degraders.
